Bad Soden, Germany

Peter Schindler


Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 119(Granted Patents)


Location History:

  • Rodgau, DE (1982 - 1984)
  • Morfelden-Walldorf, DE (1984 - 1994)
  • Bad Soden, DE (1995 - 2007)

Company Filing History:


Years Active: 1982-2007

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Peter Schindler: Innovator in Soluble Guanylate Cyclase Research

Introduction: Peter Schindler, an esteemed inventor based in Bad Soden, Germany, has made significant contributions to the field of biochemistry and pharmacology. With a remarkable portfolio of 12 patents, his work primarily focuses on the detection and stimulation of soluble guanylate cyclase, an important enzyme with implications in various therapeutic areas.

Latest Patents: Among Peter Schindler's latest innovations are groundbreaking patents that explore methods for screening activators of soluble guanylate cyclase with oxidized heme iron. This invention details methods for detecting soluble guanylate cyclase in its trivalent oxidation state and finding chemical substances that enhance its activity. Additionally, he has developed diagnostic aids and kits specifically designed for this purpose. Another noteworthy patent encompasses a luminescent method for detecting soluble guanylate cyclase, once again focusing on the enzyme’s characteristics when its heme iron is oxidized.

Career Highlights: Over the course of his career, Schindler has been associated with prominent companies, such as Hoechst Aktiengesellschaft and Aventis Pharma Deutschland GmbH. His work at these organizations has allowed him to further refine his research and contribute to advancements in the understanding of guanylate cyclase.

Collaborations: Throughout his journey, Peter has collaborated with notable colleagues, including Ursula Schindler and Hartmut Strobel. These partnerships have enriched his research and fostered an environment of innovative thinking and problem-solving.

Conclusion: Peter Schindler stands out as a key figure in the domain of enzyme research, particularly in the mechanisms and applications of soluble guanylate cyclase. His extensive patent portfolio not only reflects his dedication to innovation but also highlights the potential impact of his inventions in the medical and scientific communities. As research continues to unfold in this area, Schindler's contributions will undoubtedly play a significant role in future therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…